Medpace Holdings, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Medpace Holdings, Inc. (MEDP) reported Increase (Decrease) in Prepaid Expense and Other Assets of $15.95 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-07-23
- Medpace Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $14.15M, a 9.14% decline year-over-year.
- Medpace Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $1.79M, a 89.77% decline year-over-year.
- Medpace Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $11.49M, a 1070.47% increase year-over-year.
- Medpace Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$17.52M.
- Medpace Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $27.10M, a 124.16% increase from fiscal 2024.
- Medpace Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $12.09M.
- Medpace Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$2.99M, a 129.35% decline from fiscal 2022.
- Medpace Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $10.18M, a 11.40% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $15.95M 10-Q · filed 2026-07-23 | $27.44M derived: sum of 3 quarters · filed 2026-07-23 | $9.92M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $1.79M 10-Q · filed 2026-04-23 | $13.29M derived: sum of 2 quarters · filed 2026-04-23 | -$4.23M derived: sum of 3 quarters · filed 2026-04-23 | $11.34M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $11.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$6.03M derived: sum of 2 quarters · filed 2026-02-10 | $9.55M derived: sum of 3 quarters · filed 2026-07-23 | $27.10M 10-K · filed 2026-02-10 |
| 2025-09-30 | -$17.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | -$1.95M derived: sum of 2 quarters · filed 2026-07-23 | $15.61M 10-Q · filed 2025-10-23 | $16.59M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $15.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $33.13M 10-Q · filed 2026-07-23 | $34.11M derived: sum of 3 quarters · filed 2026-07-23 | $33.97M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $17.55M 10-Q · filed 2026-04-23 | $18.54M derived: sum of 2 quarters · filed 2026-04-23 | $18.39M derived: sum of 3 quarters · filed 2026-04-23 | $20.44M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $982.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $839.00K derived: sum of 2 quarters · filed 2026-02-10 | $2.88M derived: sum of 3 quarters · filed 2026-02-10 | $12.09M 10-K · filed 2026-02-10 |
| 2024-09-30 | -$143.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $1.90M derived: sum of 2 quarters · filed 2025-10-23 | $11.11M 10-Q · filed 2025-10-23 | -$832.00K derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $11.25M 10-Q · filed 2025-07-22 | -$689.00K derived: sum of 3 quarters · filed 2026-02-10 | -$3.57M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $9.21M 10-Q · filed 2025-04-22 | -$2.73M derived: sum of 2 quarters · filed 2026-02-10 | -$5.61M derived: sum of 3 quarters · filed 2026-02-10 | -$3.99M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | -$11.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$14.82M derived: sum of 2 quarters · filed 2026-02-10 | -$13.19M derived: sum of 3 quarters · filed 2026-02-10 | -$2.99M 10-K · filed 2026-02-10 |
| 2023-09-30 | -$2.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-22 | -$1.25M derived: sum of 2 quarters · filed 2024-10-22 | $8.95M 10-Q · filed 2024-10-22 | $1.73M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | $1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-23 | $11.83M 10-Q · filed 2024-07-23 | $4.61M derived: sum of 3 quarters · filed 2025-02-11 | $3.22M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $10.21M 10-Q · filed 2024-04-23 | $2.98M derived: sum of 2 quarters · filed 2025-02-11 | $1.59M derived: sum of 3 quarters · filed 2025-02-11 | $14.83M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | -$7.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | -$8.61M derived: sum of 2 quarters · filed 2025-02-11 | $4.63M derived: sum of 3 quarters · filed 2025-02-11 | $10.18M 10-K · filed 2025-02-11 |
| 2022-09-30 | -$1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-24 | $11.85M derived: sum of 2 quarters · filed 2023-10-24 | $17.40M 10-Q · filed 2023-10-24 | $4.48M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $13.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $18.79M 10-Q · filed 2023-07-25 | $5.87M derived: sum of 3 quarters · filed 2024-02-13 | $13.03M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $5.55M 10-Q · filed 2023-04-25 | -$7.37M derived: sum of 2 quarters · filed 2024-02-13 | -$208.00K derived: sum of 3 quarters · filed 2024-02-13 | $8.61M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | -$12.91M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | -$5.75M derived: sum of 2 quarters · filed 2024-02-13 | $3.06M derived: sum of 3 quarters · filed 2024-02-13 | $9.13M 10-K · filed 2024-02-13 |
| 2021-09-30 | $7.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $15.98M derived: sum of 2 quarters · filed 2022-10-25 | $22.05M 10-Q · filed 2022-10-25 | $15.95M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $8.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-26 | $14.89M 10-Q · filed 2022-07-26 | $8.79M derived: sum of 3 quarters · filed 2023-02-14 | $17.75M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $6.07M 10-Q · filed 2022-04-26 | -$23.00K derived: sum of 2 quarters · filed 2023-02-14 | $8.94M derived: sum of 3 quarters · filed 2023-02-14 | $7.10M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | -$6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $2.86M derived: sum of 2 quarters · filed 2023-02-14 | $1.03M derived: sum of 3 quarters · filed 2023-02-14 | $3.72M 10-K · filed 2023-02-14 |
| 2020-09-30 | $8.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-26 | $7.13M derived: sum of 2 quarters · filed 2021-10-26 | $9.82M 10-Q · filed 2021-10-26 | $8.16M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $860.00K 10-Q · filed 2021-07-27 | -$798.00K derived: sum of 3 quarters · filed 2022-02-15 | $4.83M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $2.69M 10-Q · filed 2021-04-27 | $1.04M derived: sum of 2 quarters · filed 2022-02-15 | $6.66M derived: sum of 3 quarters · filed 2022-02-15 | $8.43M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | -$1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $3.97M derived: sum of 2 quarters · filed 2022-02-15 | $5.74M derived: sum of 3 quarters · filed 2022-02-15 | $7.38M 10-K · filed 2022-02-15 |
| 2019-09-30 | $5.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $7.40M derived: sum of 2 quarters · filed 2020-10-27 | $9.04M 10-Q · filed 2020-10-27 | $7.74M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $3.41M 10-Q · filed 2020-07-28 | $2.11M derived: sum of 3 quarters · filed 2021-02-16 | $3.85M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $1.64M 10-Q · filed 2020-04-29 | $341.00K derived: sum of 2 quarters · filed 2021-02-16 | $2.08M derived: sum of 3 quarters · filed 2021-02-16 | $2.67M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $437.00K derived: sum of 2 quarters · filed 2021-02-16 | $1.03M derived: sum of 3 quarters · filed 2021-02-16 | $1.24M 10-K · filed 2021-02-16 |
| 2018-09-30 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $2.33M derived: sum of 2 quarters · filed 2019-10-29 | $2.54M 10-Q · filed 2019-10-29 | $4.80M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $590.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $804.00K 10-Q · filed 2019-07-30 | $3.07M derived: sum of 3 quarters · filed 2020-02-25 | $3.82M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $214.00K 10-Q · filed 2019-04-30 | $2.48M derived: sum of 2 quarters · filed 2020-02-25 | $3.23M derived: sum of 3 quarters · filed 2020-02-25 | $3.50M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $3.01M derived: sum of 2 quarters · filed 2020-02-25 | $3.29M derived: sum of 3 quarters · filed 2020-02-25 | $3.53M 10-K · filed 2020-02-25 |
| 2017-09-30 | $752.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $1.02M derived: sum of 2 quarters · filed 2018-10-30 | $1.27M 10-Q · filed 2018-10-30 | -$3.80M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $272.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $519.00K 10-Q · filed 2018-07-31 | -$4.55M derived: sum of 3 quarters · filed 2019-02-26 | -$4.37M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $247.00K 10-Q · filed 2018-05-01 | -$4.83M derived: sum of 2 quarters · filed 2019-02-26 | -$4.64M derived: sum of 3 quarters · filed 2019-02-26 | $2.64M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | -$5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$4.89M derived: sum of 2 quarters · filed 2019-02-26 | $2.40M derived: sum of 3 quarters · filed 2019-02-26 | $3.66M 10-K · filed 2019-02-26 |
| 2016-09-30 | $182.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $7.47M derived: sum of 2 quarters · filed 2017-10-31 | $8.73M 10-Q · filed 2017-10-31 | $8.20M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $7.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $8.55M 10-Q · filed 2017-08-01 | $8.02M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2016-03-31 | $1.26M 10-Q · filed 2017-05-02 | $728.00K derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2015-12-31 | -$536.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $181.00K 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $717.00K 10-Q · filed 2016-11-03 | |||
| 2014-12-31 | $846.00K 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |